Rhinorus, 0.05% spray 20 ml

Pharmacotherapeutic group: anticongestinal agent – alpha-adrenomimetic

ATC code: R01AA07

Pharmacodynamics:

Indications

Active ingredient

Composition

Active substance:

xylometazoline hydrochloride 0.5 mg;

Auxiliary substances:

benzalkonium chloride,

sodium chloride,

disodium edetate,

sodium dihydrophosphate dihydrate,

How to take, the dosage

Adults and children over 6 years of age – 1 injection of nasal spray 0.1% in each nasal passage 3 times/day. If necessary, it is possible to repeat the injection (not more than two injections at a time).

In children from 2 to 6 years of age – 1 injection of 0.05% nasal spray in each nostril 1-2 times a day.

The drug should not be used more than 3 times a day. The treatment duration is not more than 5-7 days (without interruption).

After completion of therapy, the drug can only be prescribed again after a few days.

The duration of use of the drug in children is determined by the doctor.

Interaction

The systemic effects may be enhanced if monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants are used concomitantly.

Special Instructions

Do not exceed the recommended doses and use for long periods.
Nasal passages should be cleaned before use.
Do not use for more than 7 days.

Contraindications

Do not use with MAO inhibitors and tricyclic antidepressants or other drugs which increase BP.

The drug should be prescribed with caution in diabetes mellitus, CHD, angina III-IV functional class, prostatic hyperplasia, during lactation.

Side effects

Local reactions: with frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, paresthesias, sneezing, hypersecretion; rarely – swelling of the nasal mucosa.

Systemic reactions: vomiting, headache, palpitations, increased BP, insomnia, visual impairment, depression (with long-term use of high doses).

Overdose

Symptoms: increased side effects.

Treatment: symptomatic under medical supervision.

Similarities